[PDF][PDF] Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: a systematic review.
MT Lozano-López… - European Review for …, 2021 - europeanreview.org
Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol
withdrawal: a systematic review Page 1 4554 Abstract. – OBJECTIVE: This study’s main …
withdrawal: a systematic review Page 1 4554 Abstract. – OBJECTIVE: This study’s main …
[图书][B] Dual Disorder Heroin Addicts: Clinical and Therapeutical Aspects
The study of aggression is crucial in psychiatry and psychopathology because hostile
behaviours are involved in various physical pathologies and because aggression has an …
behaviours are involved in various physical pathologies and because aggression has an …
[HTML][HTML] Comorbidities of Major Depressive Disorder and Bipolar Disorders in Patients with Substance Use Disorder in Iran Psychiatric Hospital: A Cross-sectional …
Background Mood disorders are the most common psychiatric comorbidities in substance
users. Mood disorders and substance use disorders are 2 intertwined processes in which …
users. Mood disorders and substance use disorders are 2 intertwined processes in which …
Hospitalizações por perturbação bipolar e perturbações do uso de substâncias: Um estudo nacional retrospetivo entre 2008 e 2015
LS da Silva Valente - 2024 - repositorio-aberto.up.pt
Background: Bipolar Disorder (BD) is a severe and chronic mental disorder often
complicated by co-occurring substance use disorders (SUD). This study aimed to assess the …
complicated by co-occurring substance use disorders (SUD). This study aimed to assess the …
Mood Disorders in Dual Disorder Heroin Use Disorder Patients
An index episode of moderate depression characterized one patient out of three entering
methadone treatments, and surveys quote similar rates among large groups of subjects …
methadone treatments, and surveys quote similar rates among large groups of subjects …
[PDF][PDF] Antagonist opioid medications in mental illness: State of art and future perspectives
I Maremmani, L Rovai, AGI Maremmani… - … Addiction Relat Clin …, 2015 - researchgate.net
Introduction: The involvement of the opioidergic system in the pathogenesis of various
addictive and non-addictive disorders has led to a renewed interest in expanding the clinical …
addictive and non-addictive disorders has led to a renewed interest in expanding the clinical …
Heroin-induced chronic hypomania: a case report
S Prakash, YPS Balhara, S Deepak - Journal of Substance Use, 2016 - Taylor & Francis
The mood-altering effects of opioids are well known. Besides the short lasting alteration of
mood associated with acute effects of opioids, they are also known to induce psychiatric …
mood associated with acute effects of opioids, they are also known to induce psychiatric …
Evoking subclinical hypomania as a potential autism treatment-a hypothesis based on an up-to-date literature review
M Świerczek, K Nesterowicz - Medical Research Archives, 2018 - esmed.org
The growing number of children diagnosed with autism spectrum disorder (ASD) urges the
scientific community to find a simple and cost-effective solution to this problem. Before 1990 …
scientific community to find a simple and cost-effective solution to this problem. Before 1990 …
Withdrawal Emergent Recurrent Manic Episodes with Use of “Bhukki”: A Case Report
Discussion Opioid agonists and antagonists have been studied for their psychomimetic
effects and mood-altering properties. Among the four receptors of the opioidergic system (ie …
effects and mood-altering properties. Among the four receptors of the opioidergic system (ie …
Episodio maniaco con síntomas psicóticos tras desintoxicación de heroína: estudio de un caso
AN del Rosario - Psiquiatría Biológica, 2018 - Elsevier
El uso de fármacos agonistas opioides, como la metadona, en el tratamiento de la
dependencia a la heroína es altamente frecuente. A su vez, la prevalencia de trastornos …
dependencia a la heroína es altamente frecuente. A su vez, la prevalencia de trastornos …